[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100587139":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":29,"responsibleParty":47,"collaborators":20,"id":49,"slug":20,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":20,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":20,"enrollmentInfo":57,"targetDuration":20,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":20,"overallStatus":32,"whyStopped":20,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Dr. August Wolff GmbH & Co. KG Arzneimittel","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Test Product (P-001230\u002F2)","EXPERIMENTAL","Patients receive at least two applications of the test product P-001230\u002F2 in the application area every day. An additional washing product is used to clean the skin.",[13],"Other: Protective Balm",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"OTHER","Protective Balm","The test product will be applied in addition to an additional washing product in the test area.",[9],null,[22,26],{"name":23,"role":24,"phone":20,"phoneExt":20,"email":25},"Clarissa Masur","CONTACT","clarissa.masur@drwolffgroup.com",{"name":27,"role":24,"phone":20,"phoneExt":20,"email":28},"Vanessa Letmathe","vanessa.letmathe@drwolffgroup.com",[30],{"facility":31,"status":32,"city":33,"state":20,"zip":34,"country":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Klinikum Dortmund","RECRUITING","Dortmund","33137","Germany",{"type":37,"coordinates":38},"Point",[39,40],7.466,51.51494,{"lat":40,"lon":39},[43],{"name":44,"role":24,"phone":45,"phoneExt":20,"email":46},"Prof. Dr. Thomas Reinbold","+49 231 953 19320","Thomas.Reinbold@klinikumdo.de",{"type":48,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100587139",false,"NCT06924502","Testing the Protective and Caring Effect of a Water-in-oil Formulation in Patients Suffering From Urinary and\u002For Fecal Incontinence and Requiring Incontinence Care Products","Non-controlled, Exploratory, Single-arm Clinical Study With a Water-in-oil Emulsion to Test the Protecting and Caring Effect of the Formulation on 'Incontinence-care Product Requiring' Fecal and\u002For Urinary Incontinent Patients","Inclusion Criteria:\n\n* Patient is capable of understanding the information given to them and providing informed consent\n* 70 years of age and older\n* Patients with incontinence (fecal and\u002For urinary), requiring incontinence protection material\n* Skin type on Fitzpatrick scale: Between I to IV\n\nExclusion Criteria:\n\n* Current cancer treatment such as chemotherapy, irradiation\n* Documented allergies to skin care and \u002F or skin cleansing products\n* Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, etc. at the test area that could influence the investigation\n* Incontinence-associated dermatitis (IAD) stage \\>1a\n* Active skin disease at the test area\n* Any topical medication at the test area within the last 3 days prior to the start of the study and \u002F or hroughout te entire course of the study\n* Mini-Mental-Status-Test (MMST) \\\u003C 20","ALL","70 Years",{"count":58,"type":59},40,"ESTIMATED","INTERVENTIONAL",[62],"NA","The aim of this study is to test the protecting and caring effect of a protective balm on patients suffering from urinary and\u002For fecal incontinence and need incontinence care products.",[65,66],"Incontinence, Urinary","Incontinence, Fecal","2025-07-17",{"date":69,"type":70},"2025-07-18","ACTUAL",{"date":72,"type":70},"2025-06-06",{"date":74,"type":59},"2025-11",{"name":5,"class":6},1]